Use of Roche’s haemophilia A therapy Hemlibra expanded in the US by Selina McKee | Oct 5, 2018 | News | 0 Roche’s Hemlibra has been approved in the US for routine prophylaxis of bleeding episodes patients with haemophilia A without factor VIII inhibitors. Read More